Global Premenstrual Dysphoric Disorder (PMDD) Market Size, Status and Forecast 2024-2031

Report ID: 934316 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Table Product
        1.2.3 Inject Product
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Perspective (2016-2027)
    2.2 Premenstrual Dysphoric Disorder (PMDD) Growth Trends by Regions
        2.2.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Premenstrual Dysphoric Disorder (PMDD) Historic Market Share by Regions (2016-2021)
        2.2.3 Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Regions (2022-2027)
    2.3 Premenstrual Dysphoric Disorder (PMDD) Industry Dynamic
        2.3.1 Premenstrual Dysphoric Disorder (PMDD) Market Trends
        2.3.2 Premenstrual Dysphoric Disorder (PMDD) Market Drivers
        2.3.3 Premenstrual Dysphoric Disorder (PMDD) Market Challenges
        2.3.4 Premenstrual Dysphoric Disorder (PMDD) Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Revenue
        3.1.1 Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Revenue (2016-2021)
        3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Players (2016-2021)
    3.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Premenstrual Dysphoric Disorder (PMDD) Revenue
    3.4 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio
        3.4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2020
    3.5 Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Area Served
    3.6 Key Players Premenstrual Dysphoric Disorder (PMDD) Product Solution and Service
    3.7 Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Premenstrual Dysphoric Disorder (PMDD) Breakdown Data by Type
    4.1 Global Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Type (2016-2021)
    4.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Type (2022-2027)

5 Premenstrual Dysphoric Disorder (PMDD) Breakdown Data by Application
    5.1 Global Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Application (2016-2021)
    5.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
    6.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
        6.2.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
        6.2.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
        6.2.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
    6.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
        6.3.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
        6.3.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
        6.3.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
    6.4 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
        6.4.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021)
        6.4.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
    7.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
        7.2.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
        7.2.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
        7.2.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
    7.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
        7.3.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
        7.3.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
        7.3.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
    7.4 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
        7.4.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021)
        7.4.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
    8.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
        8.2.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
    8.3 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
        8.3.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
    8.4 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region
        8.4.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
    9.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
        9.2.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
        9.2.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
        9.2.3 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
    9.3 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
        9.3.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
        9.3.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
        9.3.3 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
    9.4 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
        9.4.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021)
        9.4.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
    10.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
        10.2.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
    10.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
        10.3.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
    10.4 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
        10.4.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Teva
        11.1.1 Teva Company Details
        11.1.2 Teva Business Overview
        11.1.3 Teva Premenstrual Dysphoric Disorder (PMDD) Introduction
        11.1.4 Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
        11.1.5 Teva Recent Development
    11.2 Eli Liliy
        11.2.1 Eli Liliy Company Details
        11.2.2 Eli Liliy Business Overview
        11.2.3 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Introduction
        11.2.4 Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
        11.2.5 Eli Liliy Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Premenstrual Dysphoric Disorder (PMDD) Introduction
        11.3.4 Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
        11.3.5 Pfizer Recent Development
    11.4 Bayer
        11.4.1 Bayer Company Details
        11.4.2 Bayer Business Overview
        11.4.3 Bayer Premenstrual Dysphoric Disorder (PMDD) Introduction
        11.4.4 Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
        11.4.5 Bayer Recent Development
    11.5 GSK
        11.5.1 GSK Company Details
        11.5.2 GSK Business Overview
        11.5.3 GSK Premenstrual Dysphoric Disorder (PMDD) Introduction
        11.5.4 GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
        11.5.5 GSK Recent Development
    11.6 Apotex
        11.6.1 Apotex Company Details
        11.6.2 Apotex Business Overview
        11.6.3 Apotex Premenstrual Dysphoric Disorder (PMDD) Introduction
        11.6.4 Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
        11.6.5 Apotex Recent Development
    11.7 Bristol Laboratories
        11.7.1 Bristol Laboratories Company Details
        11.7.2 Bristol Laboratories Business Overview
        11.7.3 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Introduction
        11.7.4 Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
        11.7.5 Bristol Laboratories Recent Development
    11.8 Mylan
        11.8.1 Mylan Company Details
        11.8.2 Mylan Business Overview
        11.8.3 Mylan Premenstrual Dysphoric Disorder (PMDD) Introduction
        11.8.4 Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
        11.8.5 Mylan Recent Development
    11.9 Allergan
        11.9.1 Allergan Company Details
        11.9.2 Allergan Business Overview
        11.9.3 Allergan Premenstrual Dysphoric Disorder (PMDD) Introduction
        11.9.4 Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
        11.9.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Table Product
    Table 3. Key Players of Inject Product
    Table 4. Key Players of Others
    Table 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2016-2021)
    Table 9. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2022-2027)
    Table 11. Premenstrual Dysphoric Disorder (PMDD) Market Trends
    Table 12. Premenstrual Dysphoric Disorder (PMDD) Market Drivers
    Table 13. Premenstrual Dysphoric Disorder (PMDD) Market Challenges
    Table 14. Premenstrual Dysphoric Disorder (PMDD) Market Restraints
    Table 15. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Players (2016-2021)
    Table 17. Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2020)
    Table 18. Ranking of Global Top Premenstrual Dysphoric Disorder (PMDD) Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Premenstrual Dysphoric Disorder (PMDD) Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Premenstrual Dysphoric Disorder (PMDD) Product Solution and Service
    Table 22. Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2016-2021)
    Table 26. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Application (2016-2021)
    Table 30. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Teva Company Details
    Table 63. Teva Business Overview
    Table 64. Teva Premenstrual Dysphoric Disorder (PMDD) Product
    Table 65. Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
    Table 66. Teva Recent Development
    Table 67. Eli Liliy Company Details
    Table 68. Eli Liliy Business Overview
    Table 69. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product
    Table 70. Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
    Table 71. Eli Liliy Recent Development
    Table 72. Pfizer Company Details
    Table 73. Pfizer Business Overview
    Table 74. Pfizer Premenstrual Dysphoric Disorder (PMDD) Product
    Table 75. Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
    Table 76. Pfizer Recent Development
    Table 77. Bayer Company Details
    Table 78. Bayer Business Overview
    Table 79. Bayer Premenstrual Dysphoric Disorder (PMDD) Product
    Table 80. Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
    Table 81. Bayer Recent Development
    Table 82. GSK Company Details
    Table 83. GSK Business Overview
    Table 84. GSK Premenstrual Dysphoric Disorder (PMDD) Product
    Table 85. GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
    Table 86. GSK Recent Development
    Table 87. Apotex Company Details
    Table 88. Apotex Business Overview
    Table 89. Apotex Premenstrual Dysphoric Disorder (PMDD) Product
    Table 90. Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
    Table 91. Apotex Recent Development
    Table 92. Bristol Laboratories Company Details
    Table 93. Bristol Laboratories Business Overview
    Table 94. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product
    Table 95. Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
    Table 96. Bristol Laboratories Recent Development
    Table 97. Mylan Company Details
    Table 98. Mylan Business Overview
    Table 99. Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
    Table 100. Mylan Recent Development
    Table 101. Allergan Company Details
    Table 102. Allergan Business Overview
    Table 103. Allergan Premenstrual Dysphoric Disorder (PMDD) Product
    Table 104. Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
    Table 105. Allergan Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Type: 2020 VS 2027
    Figure 2. Table Product Features
    Figure 3. Inject Product Features
    Figure 4. Others Features
    Figure 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Others Case Studies
    Figure 9. Premenstrual Dysphoric Disorder (PMDD) Report Years Considered
    Figure 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Premenstrual Dysphoric Disorder (PMDD) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions: 2020 VS 2027
    Figure 13. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2022-2027)
    Figure 14. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Players in 2020
    Figure 15. Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2020
    Figure 17. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2016-2021)
    Figure 18. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2022-2027)
    Figure 19. North America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
    Figure 21. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
    Figure 22. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2016-2027)
    Figure 23. United States Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
    Figure 27. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
    Figure 28. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2016-2027)
    Figure 29. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Share by Region (2016-2027)
    Figure 39. China Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
    Figure 47. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
    Figure 48. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2016-2027)
    Figure 49. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2016-2027)
    Figure 55. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Teva Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
    Figure 59. Eli Liliy Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
    Figure 60. Pfizer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
    Figure 61. Bayer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
    Figure 62. GSK Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
    Figure 63. Apotex Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
    Figure 64. Bristol Laboratories Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
    Figure 65. Mylan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
    Figure 66. Allergan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva
Eli Liliy
Pfizer
Bayer
GSK
Apotex
Bristol Laboratories
Mylan
Allergan
Frequently Asked Questions
Premenstrual Dysphoric Disorder (PMDD) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Premenstrual Dysphoric Disorder (PMDD) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Premenstrual Dysphoric Disorder (PMDD) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bare Metal Servers

A bare metal server is a physical server dedicated to a single tenant. The server’s tenant can ... Read More